| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/03/2005 | US6887677 For anti-bacterial agents/inhibiting development of drug resistant strains |
| 05/03/2005 | US6887676 For diagnosis/therapy/prevention of Creutzfeldt-Jacob disease |
| 05/03/2005 | US6887674 Artery- and vein-specific proteins and uses therefor |
| 05/03/2005 | US6887670 For drug screening; solid phase synthesis; fusion proteins; genetic engineering |
| 05/03/2005 | US6887668 Using high-resolution buffer; allows reduced local Joule heating, 10-100 fold electric fields, resulting in high speed runs, improved resolution, high reproducibility; well suited for automation |
| 05/03/2005 | US6887667 Method and apparatus to identify small variations of biomolecules |
| 05/03/2005 | US6887666 Methods for identification of identical nucleic acid fragments from different nucleic acid populations |
| 05/03/2005 | US6887665 Forming a surface comprising photosensitive compound or group, an autocatalytic compound or group, compound capable of introducing latency irradiating at least a part of surface to remove protective group |
| 05/03/2005 | US6887664 Thermal cycling protocol for nucleic acid amplification uses two primers with different thermal melting temperatures |
| 05/03/2005 | US6887662 Oligonucleotides and assemblies thereof useful in the detection of the presence or absence of target nucleic acid sequences in a sample |
| 05/03/2005 | US6887661 Recombinant bHLH-PAS/JHR polypeptide and its use to screen potential insecticides |
| 05/03/2005 | US6887660 Detecting cancer in humans; obtain sample, incubate with binding protein, detect bound proteins or polypeptides, presence of bound protein indicates cancer |
| 05/03/2005 | US6887659 A quantitative analyzing the concentration of peptide with monoclonal antibody produced by the fused cell hybrid; medical diagnosis |
| 05/03/2005 | US6887658 For drug screening/high throughput assay; aggregation antagonists |
| 05/03/2005 | US6887426 Reagent strip for use in detection and monitoring glucose in erythrocytes |
| 05/03/2005 | US6887377 Affinity matrices with enhanced visibility for molecular pull-down and immunoprecipitation applications |
| 05/03/2005 | US6887210 Devices and methods for obtaining mammary fluid samples for evaluating breast diseases, including cancer |
| 05/03/2005 | CA2317732C Improved cycle sequencing thermal profiles |
| 04/30/2005 | CA2486322A1 Printing growth medium for culture and analysis of biological material |
| 04/30/2005 | CA2485854A1 Enzime activities and ph tests for the determination of the risk of obstetric and gynecologic complications in samples of body fluids of women |
| 04/28/2005 | WO2005038968A2 Suspension for the generation of a current of electrons and the use and the preparation thereof |
| 04/28/2005 | WO2005038618A2 Lead molecule cross-reaction prediction and optimization system |
| 04/28/2005 | WO2005038596A2 Method and apparatus for estimation of the electrostatic affinity between molecules using a basis expansion |
| 04/28/2005 | WO2005038459A2 Bridged element for detection of a target substance |
| 04/28/2005 | WO2005038454A1 In vitro method for the diagnosis of cardiovascular functionality of bone marrow precursor cells (bmp) and/or circulation precursor cells derived from blood (bdp) |
| 04/28/2005 | WO2005038452A1 Method and apparatus for analysis of molecular combination based on computations of shape complementarity using basis expansions |
| 04/28/2005 | WO2005038431A2 Method and device for partitioning a molecule |
| 04/28/2005 | WO2005038430A2 Viral fibers |
| 04/28/2005 | WO2005038427A2 Rapid identification of viruses of the upper respiratory tract infection including sars causing coronus viruses |
| 04/28/2005 | WO2005038370A2 Genetic markers for obesity |
| 04/28/2005 | WO2005038057A1 Classification of patients having diffuse large b-cell lymphoma based upon gene expression |
| 04/28/2005 | WO2005038054A1 METHOD OF MEASURING THE EFFICACY OF siRNA MOLECULES |
| 04/28/2005 | WO2005038053A1 Biochip analysis system and diagnosis system having biochip analysis apparatus |
| 04/28/2005 | WO2005038052A2 Method for identifying interferon mimics |
| 04/28/2005 | WO2005038051A2 Improved bisulfite conversion of dna |
| 04/28/2005 | WO2005038050A1 Method for identification of suitable fragmentation sites in a reporter protein |
| 04/28/2005 | WO2005038049A2 System and method for optimizing drug therapy |
| 04/28/2005 | WO2005038048A1 Apparatus and methods for detecting nucleic acid in biological samples |
| 04/28/2005 | WO2005038047A1 Assessment of disease risk by quantitative determination of epimutation in normal tissues |
| 04/28/2005 | WO2005038046A1 Methylation-based diagnostic method |
| 04/28/2005 | WO2005038045A1 Method and kit for measuring the activity of factor xiii |
| 04/28/2005 | WO2005038044A1 Method of treating cells |
| 04/28/2005 | WO2005038043A2 Methods of detecting poly (adp-ribose) polymerase and other nad+utilizing enzymes |
| 04/28/2005 | WO2005038042A2 Systems and methods for assessing neuronal degeneration |
| 04/28/2005 | WO2005038041A2 Direct nucleic acid detection in bodily fluids |
| 04/28/2005 | WO2005038039A2 Method for multiplex primer based amplification of nucleic acids |
| 04/28/2005 | WO2005038035A2 Methods for producing and using in vivo pseudotyped retroviruses |
| 04/28/2005 | WO2005038026A1 Method of typing mutation |
| 04/28/2005 | WO2005038022A1 Bone and/or joint disease-associated gene |
| 04/28/2005 | WO2005038013A1 Artisense oligonucleotides optimized for kidney targeting |
| 04/28/2005 | WO2005038005A2 Shc proteins as therapeutic targets in proliferative diseases |
| 04/28/2005 | WO2005037998A2 Methods and compositions related to a matrix chip |
| 04/28/2005 | WO2005037997A2 Competition assay for identifying modulators of quadruplex nucleic acids |
| 04/28/2005 | WO2005037996A2 In vitro development of tissues and organs |
| 04/28/2005 | WO2005037991A2 Interacts with ice1 and regulates cbf expression and freezing tolerance in arabidopsis |
| 04/28/2005 | WO2005037856A2 Multifunctional biomaterials as scaffolds for electronic, optical, magnetic, semiconducting, and biotechnological applications |
| 04/28/2005 | WO2005037433A1 Microfluidic device for carrying out a reaction |
| 04/28/2005 | WO2005037232A2 Methods and compositions for modulating adipocyte function |
| 04/28/2005 | WO2005037231A2 Methods of detecting and treating facioscapulohumeral muscular dystrophy |
| 04/28/2005 | WO2005037228A2 Halogen phosphonate monoesters |
| 04/28/2005 | WO2005037204A2 Ntrk1 genetic markers associated with age of onset of alzheimer's disease |
| 04/28/2005 | WO2005037194A2 Collagen interactions with prostate cancer cells |
| 04/28/2005 | WO2005037083A2 Mn/ca ix and cancer prognosis |
| 04/28/2005 | WO2005037071A2 Receptor tyrosine kinase signaling pathway analysis for diagnosis and therapy |
| 04/28/2005 | WO2005024059A3 Methods for identifying compounds for inhibiting fever |
| 04/28/2005 | WO2005021775A3 Method for identifying selective growth inhibitors |
| 04/28/2005 | WO2005017521A3 Techniques for recording signals |
| 04/28/2005 | WO2005014860A3 Biomolecule analysis by rolling circle amplification and sers detection |
| 04/28/2005 | WO2005013889A3 Truncated fragments of alpha-synuclein in lewy body disease |
| 04/28/2005 | WO2005010160A3 Liquid crystals with reduced toxicity and applications thereof |
| 04/28/2005 | WO2005007886A3 Method for displaying and selecting a protease molecule |
| 04/28/2005 | WO2005003371A3 Erk7 and erk8, novel diagnostic markers for cancer |
| 04/28/2005 | WO2005001113A3 Methods for detecting nucleic acid variations |
| 04/28/2005 | WO2004113571A3 Prostate specific genes and the use thereof as targets for prostate cancer therapy and diagnosis |
| 04/28/2005 | WO2004112570A3 Detection of survivin in the biological fluids of cancer patients |
| 04/28/2005 | WO2004111180A3 Methods and compositions for selectively enriching microbes |
| 04/28/2005 | WO2004106553A3 Nucleotide sequences specific to yersinia pestis and methods for the detection of yersinia pestis |
| 04/28/2005 | WO2004099379A3 Use of jag2 expression in diagnosis of plasma cell disorders |
| 04/28/2005 | WO2004098634A3 Protein arginine n-methyltransferase 2 (prmt-2) |
| 04/28/2005 | WO2004098531A3 Increased transduction using abc transporter substrates and/or inhibitors |
| 04/28/2005 | WO2004096832A3 Novel antiangiogenic peptides |
| 04/28/2005 | WO2004095216A3 The symmetry relationships between pairs of connectrons |
| 04/28/2005 | WO2004085049A3 Preparation and application of encoded bead aggregates in combinatorial chemistry |
| 04/28/2005 | WO2004064784A3 Composition and method for preventing or treating a virus infection |
| 04/28/2005 | WO2004061416A3 Methods for attaching molecules |
| 04/28/2005 | WO2004052309A3 Modulation of stat 6 expression |
| 04/28/2005 | WO2004052080A3 Regulome arrays |
| 04/28/2005 | WO2004050833A3 Glyceraldehyde 3-phosphate dehydrogenase-s(gapds), a glycolytic enzyme expressed only in male germ cells,is a target for male contraception |
| 04/28/2005 | WO2004049907A3 Compositions and methods for treating transplants |
| 04/28/2005 | WO2004048548A3 Methods for identifying risk of breast cancer and treatments thereof |
| 04/28/2005 | WO2004048524A3 Modulation of stat2 expression |
| 04/28/2005 | WO2004046372A3 Improved genotyping |
| 04/28/2005 | WO2004035746A3 Susceptibility gene for myocardial infarction |
| 04/28/2005 | WO2004033631A8 Nucleic acid and polypeptide sequences from lawsonia intracellularis and methods of using |
| 04/28/2005 | WO2004032878A3 Compositions, organisms and methodologies employing a novel human kinase |
| 04/28/2005 | WO2004032839A3 Methods and formulations comprising agonists and antagonists of nuclear hormone receptors |
| 04/28/2005 | WO2004020583A8 Polynucleotide predictor set for identifying protein tyrosine kinase modulators |
| 04/28/2005 | WO2004020065A3 Microfluidic affinity system using polydimethylsiloxane and a surface modification process |
| 04/28/2005 | WO2004004666A3 Modulators of leukocyte activation, hck compositions and methods of use |
| 04/28/2005 | WO2003104424A3 Novel molecular conjugates for signal amplification |